Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BioLineRx Announces Partial Monotherapy Results From Phase IIa COMBAT Study in Pancreatic Cancer

biospaceJanuary 18, 2018

Tag: BioLineRx , Pancreatic cancer

PharmaSources Customer Service